Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 501–520 of 17,529 recalls

July 18, 2025· AEQUITA PHARMACY

Recalled Item: Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 18, 2025· AEQUITA PHARMACY

Recalled Item: Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol

The Issue: Lack of Processing Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 17, 2025· DermaRite Industries, LLC

Recalled Item: PeriGiene

The Issue: Microbial Contamination of Non-Sterile Drug Product: The products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
July 17, 2025· DermaRite Industries, LLC

Recalled Item: DermaSarra

The Issue: Microbial Contamination of Non-Sterile Drug Product: The products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
July 17, 2025· DermaRite Industries, LLC

Recalled Item: DermaKleen

The Issue: Microbial Contamination of Non-Sterile Drug Product: The products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
July 17, 2025· DermaRite Industries, LLC

Recalled Item: KleenFoam

The Issue: Microbial Contamination of Non-Sterile Drug Product: The products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
July 15, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 11, 2025· Nostrum Laboratories, Inc.

Recalled Item: Sucralfate Tablets

The Issue: CGMP Deviations: The recalling firm filed for Chapter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 10, 2025· Pfizer Inc.

Recalled Item: Bicillin L-A (penicllin G benzathine injectable suspension)

The Issue: CGMP Deviations; particulates identified during visual inspection

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 10, 2025· Pfizer Inc.

Recalled Item: Bicillin L-A (penicillin G benzathine injectable suspension)

The Issue: CGMP Deviations; particulates identified during visual inspection

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 10, 2025· A.P. Deauville, LLC

Recalled Item: Power Stick for her PH Balanced Roll-On Antiperspirant Deodorant with

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 10, 2025· A.P. Deauville, LLC

Recalled Item: Beauty & Skincare Power Stick original nourishing invisible protection roll-on

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 10, 2025· A.P. Deauville, LLC

Recalled Item: Shave and Skincare Power Stick Original Nourishing Invisible Protection Roll-On

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 9, 2025· Boothwyn Pharmacy LLC

Recalled Item: Semaglutide

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 9, 2025· Boothwyn Pharmacy LLC

Recalled Item: Fluorescein 2% Ophth

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
July 9, 2025· Boothwyn Pharmacy LLC

Recalled Item: Semaglutide

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 9, 2025· Boothwyn Pharmacy LLC

Recalled Item: Semaglutide

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 9, 2025· Strides Pharma, Inc.

Recalled Item: Cinacalcet Tablets 90 mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 9, 2025· Imprimis NJOF, LLC

Recalled Item: Tropicamide-Proparacaine-Phenylephrine-Ketorolac

The Issue: Sub-Potent Drug: Subpotent assay results during stability testing

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund